Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors

Title
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 16, Issue 1, Pages 43-51
Publisher
Informa UK Limited
Online
2014-12-09
DOI
10.4161/15384047.2014.986967

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started